deltatrials
Recruiting OBSERVATIONAL NCT04672733

Hizentra® in Inflammatory Neuropathies - pHeNIx Study (pHeNIx)

Sponsor: CSL Behring

Interventions Hizentra
Updated 26 times since 2021 Last updated: Jan 6, 2025 Started: Jun 10, 2022 Primary completion: Dec 31, 2027 Completion: Dec 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04672733, this observational or N/A phase trial focuses on Chronic Inflammatory Demyelinating Polyneuropathy and remains actively recruiting participants. Sponsored by CSL Behring, it has been updated 26 times since 2022, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Apr 2021 · 59 days · monthly snapshot~Apr 2021 – ~May 2021 · 30 days · monthly snapshot~May 2021 – ~Sep 2021 · 4 months · monthly snapshot~Sep 2021 – ~Mar 2022 · 6 months · monthly snapshot~Mar 2022 – ~Apr 2022 · 31 days · monthly snapshot~Apr 2022 – ~Jun 2022 · 2 months · monthly snapshot~Jun 2022 – ~Jul 2022 · 30 days · monthly snapshot~Jul 2022 – ~Nov 2022 · 4 months · monthly snapshot~Nov 2022 – ~Dec 2022 · 30 days · monthly snapshot~Dec 2022 – ~Feb 2023 · 2 months · monthly snapshot~Feb 2023 – ~Mar 2023 · 28 days · monthly snapshot~Mar 2023 – ~Apr 2023 · 31 days · monthly snapshot~Apr 2023 – ~Aug 2023 · 4 months · monthly snapshot~Aug 2023 – ~Oct 2023 · 2 months · monthly snapshot~Oct 2023 – ~Nov 2023 · 31 days · monthly snapshot~Nov 2023 – ~Dec 2023 · 30 days · monthly snapshot~Dec 2023 – ~Jan 2024 · 31 days · monthly snapshot~Jan 2024 – ~May 2024 · 4 months · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshot~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshot~Jan 2025 – ~Feb 2025 · 31 days · monthly snapshot~Feb 2025 – ~Sep 2025 · 7 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

26 versions recorded
  1. Sep 2025 — Present [monthly]

    Recruiting

  2. Feb 2025 — Sep 2025 [monthly]

    Recruiting

  3. Jan 2025 — Feb 2025 [monthly]

    Recruiting

  4. Sep 2024 — Jan 2025 [monthly]

    Recruiting

  5. Aug 2024 — Sep 2024 [monthly]

    Recruiting

Show 21 earlier versions
  1. Jul 2024 — Aug 2024 [monthly]

    Recruiting

  2. May 2024 — Jul 2024 [monthly]

    Recruiting

  3. Jan 2024 — May 2024 [monthly]

    Recruiting

  4. Dec 2023 — Jan 2024 [monthly]

    Recruiting

  5. Nov 2023 — Dec 2023 [monthly]

    Recruiting

  6. Oct 2023 — Nov 2023 [monthly]

    Recruiting

  7. Aug 2023 — Oct 2023 [monthly]

    Recruiting

  8. Apr 2023 — Aug 2023 [monthly]

    Recruiting

  9. Mar 2023 — Apr 2023 [monthly]

    Recruiting

  10. Feb 2023 — Mar 2023 [monthly]

    Recruiting

  11. Dec 2022 — Feb 2023 [monthly]

    Recruiting

  12. Nov 2022 — Dec 2022 [monthly]

    Recruiting

  13. Jul 2022 — Nov 2022 [monthly]

    Recruiting

  14. Jun 2022 — Jul 2022 [monthly]

    Recruiting

    Status: SuspendedRecruiting

  15. Apr 2022 — Jun 2022 [monthly]

    Suspended

  16. Mar 2022 — Apr 2022 [monthly]

    Suspended

  17. Sep 2021 — Mar 2022 [monthly]

    Suspended

    Status: Not Yet RecruitingSuspended

  18. May 2021 — Sep 2021 [monthly]

    Not Yet Recruiting

  19. Apr 2021 — May 2021 [monthly]

    Not Yet Recruiting

  20. Feb 2021 — Apr 2021 [monthly]

    Not Yet Recruiting

  21. Jan 2021 — Feb 2021 [monthly]

    Not Yet Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CSL Behring
Data source: CSL Behring

For direct contact, visit the study record on ClinicalTrials.gov .